Injectable Drug Delivery to 2020

Jan 22, 2014, 09:55 ET from Reportlinker

NEW YORK, Jan. 22, 2014 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Injectable Drug Delivery to 2020

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.


- Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injectable drug products by therapeutic indication

- Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues

- Provides detailed descriptions of key injectable drug therapeutic market segments, market demographics, and business strategies

- Forecasts Injectable drug product demand by indication and therapy to 2020

- Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations

Executive Summary

Injectable Drug Delivery Market Dynamics

The Injectable Drug Ecosystem

Injectable Drug Demand Drivers

Drug Development Factors

Market Factors

Technology Factors

Competitive Landscape


Needle-free Injectors

Pen Injectors

Prefilled Syringes

Safety Syringes

Risks and Opportunities

Injectable Drug Device Selection Criteria

Stability and Material Selection Issues

Single vs Multi-Dose Devices

Lyophilized Drugs/Reconstitution

Syringe Safety/Sharps Protection

Needle Configuration Strategies

Disposable Drug Cartridges

Human Engineering/Ergonomics

Branding/Private Labeling

Injectable Drug Delivery – Device Segments


Autoinjector-specific Selection Factors

Part Counts and Device Cost

Safety Features

Needle Shielding

Needle Insertion Depth

Failsafe Activation

Dose Inspection/Injection Confirmation

Autoinjector Device Categories

Reusable Autoinjectors

Disposable Autoinjectors

Product Specific Autoinjectors

Drugs and Therapeutic Segments

Needle-free InjectorsDevice CategoriesEnd User/Practitioner/Mass Immunization InjectorsPrefilled Disposable ModelsRefillable Cartridge DesignsNeedle-free Injector-specific Selection FactorsEnergy SourceInjection Site Selection

Pen Injectors

Pen Injector Device Categories

Standardized Pen Platforms

Custom Pen Designs

Reusable Pens

Prefilled Pen Cartridges

Disposable Pens

Dual Chamber Pens

Branded Drug/Pen Injector Product by Therapeutic Segment

Prefilled SyringesPrefilled Syringe Device CategoriesGlass Prefilled SyringesPrefillable Glass Syringe Manufacturers and Branded DevicesBranded Drug/Prefilled Glass Syringe Products by Therapeutic SegmentPlastic Prefilled SyringesBranded Prefillable Plastic SyringesDrugs and Therapeutic SegmentsPrefillable Safety SyringesPrefilled Syringe-specific Selection FactorsPFS Manufacturing FactorsFill-and-Finish Operations

Safety Syringes

Safety Syringe Device Categories

Prefillable Integrated Safety Syringes

Non-Prefillable Integrated Safety Syringes

Retractable Needle

Manually Retractable

Automatic Retractable

Sliding Sheath

Injectable Drug Delivery – Therapeutic Segment Analysis & Forecasts




Autoimmune Diseases

Emergency Medicine


Hormone Replacement

Metabolic Diseases


Reproductive Health


Injectable Drug Therapeutics - Market Factors

Regulatory Factors and Issues

FDA Regulations

Regulating Combination Products

Sharps Legislations

Growth and Diversity of Safety Syringes

Sharps Disposal

Clinical Trial Factors

Managed Care and Healthcare Economics

Company Profiles

To order this report: Injectable Drug Delivery to 2020

Contact Clare:
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker